We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
Cap. Flow
+$1.69B
Cap. Flow %
19.13%
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175

Top Buys

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$78.4M
2
INFY icon
Infosys
INFY
+$65M
3
FFIV icon
F5
FFIV
+$64.6M
4
WDC icon
Western Digital
WDC
+$62.1M
5
CI icon
Cigna
CI
+$60.1M

Top Sells

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$69.1M
2
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$68.2M
3
PCYC
PHARMACYCLICS INC
PCYC
+$57.6M
4
MDT icon
Medtronic
MDT
+$51.8M
5
DRC
DRESSER-RAND GROUP INC
DRC
+$50.2M

Sector Composition

Rank Sector Weight
1 Industrials 14.28%
2 Healthcare 13.44%
3 Technology 12.36%
4 Financials 10.47%
5 Energy 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOJA
451
DELISTED
Bojangles', Inc. Common Stock
BOJA
$477K 0.01%
+20,000
New +$505K
ADMA icon
452
ADMA Biologics
ADMA
$2.22B
$471K 0.01%
50,823
+823
+2% +$7.12K
EXAS
453
DELISTED
Exact Sciences
EXAS
$464K 0.01%
15,610
-13,560
-46% -$341K
TRIL
454
DELISTED
Trillium Therapeutics Inc.
TRIL
$444K 0.01%
+20,329
New +$463K
GNMX
455
DELISTED
Aevi Genomic Medicine Inc
GNMX
$438K 0.01%
71,383
+1,155
+2% +$8.95K
CUDA
456
DELISTED
Barracuda Networks, Inc.
CUDA
$433K ﹤0.01%
+10,917
New +$448K
LINC icon
457
Lincoln Educational Services
LINC
$1.3B
$432K ﹤0.01%
214,035
+3,466
+2% +$7.86K
TTHI
458
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$415K ﹤0.01%
197,429
-32,571
-14% -$228K
SPR
459
DELISTED
Spirit AeroSystems
SPR
$408K ﹤0.01%
7,405
-456,441
-98% -$24.5M
ITCI
460
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$400K ﹤0.01%
12,515
-6,393
-34% -$162K
ROKA
461
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$396K ﹤0.01%
15,246
+246
+2% +$7.21K
DHR icon
462
Danaher
DHR
$144B
$391K ﹤0.01%
+6,795
New +$389K
ALPN
463
DELISTED
Alpine Immune Sciences Inc
ALPN
$379K ﹤0.01%
+6,250
New +$372K
MBII
464
DELISTED
Marrone Bio Innovations, Inc.
MBII
$364K ﹤0.01%
184,037
+53,506
+41% +$152K
YELL
465
DELISTED
Yellow Corporation Common Stock
YELL
$359K ﹤0.01%
+27,695
New +$413K
CYTK icon
466
CALL
Cytokinetics
CYTK
$10.4B
$340K ﹤0.01%
50,607
– –
GEVO icon
467
CALL
Gevo
GEVO
$382M
$318K ﹤0.01%
243
– –
GNCA
468
DELISTED
Genocea Biosciences, Inc.
GNCA
$308K ﹤0.01%
2,800
-9,828
-78% -$912K
CYTK icon
469
Cytokinetics
CYTK
$10.4B
$272K ﹤0.01%
40,485
– –
AET
470
DELISTED
Aetna Inc
AET
$258K ﹤0.01%
+2,022
New +$231K
CBIO
471
Crescent Biopharma
CBIO
$626M
$253K ﹤0.01%
318
+5
+2% +$4.14K
CYNA
472
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$244K ﹤0.01%
+15,000
New +$246K
EXA
473
DELISTED
EXA Corporation
EXA
$204K ﹤0.01%
+18,300
New +$207K
TLOG
474
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$196K ﹤0.01%
83,786
+1,357
+2% +$4.19K
IVTY
475
DELISTED
Invuity, Inc
IVTY
$174K ﹤0.01%
+12,351
New +$180K
17 18
19
20 21

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2015 Portfolio in Review

As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.

  • Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
  • Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
  • Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
  • Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
  • Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
  • Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.

Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.